Hydroquinone and catechol interfere with T cell cycle entry and progression through the G1 phase

Area of Science:

• Immunology
• Cell Biology
• Toxicology

Background:

• Cigarette smoking impairs pulmonary T cell responses, increasing infection risk and reducing tumor surveillance.
• Hydroquinone (HQ) and catechol, present in cigarette smoke, inhibit T cell activation and proliferation.
• Previous research indicated HQ and catechol inhibit ribonucleotide reductase, crucial for DNA synthesis.

Purpose of the Study:

• To investigate the mechanism by which HQ and catechol inhibit T cell blastogenesis.
• To determine the specific phase of the cell cycle affected by HQ and catechol.
• To identify key molecular markers regulated by HQ and catechol during T cell activation.

Main Methods:

• T cells were treated with HQ and catechol prior to stimulation.
• Cell cycle progression was analyzed using markers like c-Myc, RNA synthesis, CD71, and E2F-dependent gene expression.
• Cell viability, IL-2 production, and surface markers CD69 and CD25 were assessed.

Main Results:

• HQ and catechol inhibited T cell blastogenesis by interfering with entry and progression through the G(1) phase.
• Key activation and cell cycle markers (c-Myc, RNA synthesis, CD71, E2F) were inhibited by HQ and catechol without affecting cell viability.
• Interleukin-2 (IL-2) production and CD69/CD25 expression remained unaffected, indicating selective inhibition.

Conclusions:

• HQ and catechol disrupt specific T cell cycle events, primarily during the G(1) phase.
• These findings elucidate pathways through which cigarette smoke suppresses T cell function in the lungs.
• Understanding these mechanisms is crucial for addressing smoking-related immune dysfunction.